<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10320189</article-id>
    <article-id pub-id-type="pmid">36987846</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkad214</article-id>
    <article-id pub-id-type="publisher-id">gkad214</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Web Server Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>FuzPred: a web server for the sequence-based prediction of the context-dependent binding modes of proteins</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9224-9820</contrib-id>
        <name>
          <surname>Hatos</surname>
          <given-names>Andras</given-names>
        </name>
        <aff><institution>Department of Biomedical Sciences, University of Padova</institution>, <addr-line>Padova</addr-line>, <country country="IT">Italy</country></aff>
        <aff><institution>Department of Oncology, Lausanne University Hospital</institution>, <addr-line>Lausanne 1011</addr-line>, <country country="CH">Switzerland</country></aff>
        <aff><institution>Department of Computational Biology, University of Lausanne</institution>, <addr-line>Lausanne 1015</addr-line>, <country country="CH">Switzerland</country></aff>
        <aff><institution>Swiss Institute of Bioinformatics</institution>, <addr-line>Lausanne1015</addr-line>, <country country="CH">Switzerland</country></aff>
        <aff><institution>Swiss Cancer Center Leman</institution>, <addr-line>Lausanne 1011</addr-line>, <country country="CH">Switzerland</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Teixeira</surname>
          <given-names>João M C</given-names>
        </name>
        <aff><institution>Department of Biomedical Sciences, University of Padova</institution>, <addr-line>Padova</addr-line>, <country country="IT">Italy</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Barrera-Vilarmau</surname>
          <given-names>Susana</given-names>
        </name>
        <aff><institution>Department of Biomedical Sciences, University of Padova</institution>, <addr-line>Padova</addr-line>, <country country="IT">Italy</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Horvath</surname>
          <given-names>Attila</given-names>
        </name>
        <aff><institution>John Curtin School of Medical Research, The Australian National University</institution>, <addr-line>Acton</addr-line>, <country country="AU">Australia</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4525-7793</contrib-id>
        <name>
          <surname>Tosatto</surname>
          <given-names>Silvio C E</given-names>
        </name>
        <aff><institution>Department of Biomedical Sciences, University of Padova</institution>, <addr-line>Padova</addr-line>, <country country="IT">Italy</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3616-1610</contrib-id>
        <name>
          <surname>Vendruscolo</surname>
          <given-names>Michele</given-names>
        </name>
        <aff><institution>Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge</institution>, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4463-6727</contrib-id>
        <name>
          <surname>Fuxreiter</surname>
          <given-names>Monika</given-names>
        </name>
        <!--monika.fuxreiter@unipd.it-->
        <aff><institution>Department of Biomedical Sciences, University of Padova</institution>, <addr-line>Padova</addr-line>, <country country="IT">Italy</country></aff>
        <aff><institution>Department of Physics and Astronomy, University of Padova</institution>, <addr-line>Padova</addr-line>, <country country="IT">Italy</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +39 049 827 6136; Email: <email>monika.fuxreiter@unipd.it</email></corresp>
      <fn id="FN1">
        <p>The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <day>05</day>
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-03-29">
      <day>29</day>
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>29</day>
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <volume>51</volume>
    <issue>W1</issue>
    <fpage>W198</fpage>
    <lpage>W206</lpage>
    <history>
      <date date-type="accepted">
        <day>27</day>
        <month>3</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>01</day>
        <month>3</month>
        <year>2023</year>
      </date>
      <date date-type="received">
        <day>09</day>
        <month>1</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkad214.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Proteins form complex interactions in the cellular environment to carry out their functions. They exhibit a wide range of binding modes depending on the cellular conditions, which result in a variety of ordered or disordered assemblies. To help rationalise the binding behavior of proteins, the FuzPred server predicts their sequence-based binding modes without specifying their binding partners. The binding mode defines whether the bound state is formed through a disorder-to-order transition resulting in a well-defined conformation, or through a disorder-to-disorder transition where the binding partners remain conformationally heterogeneous. To account for the context-dependent nature of the binding modes, the FuzPred method also estimates the multiplicity of binding modes, the likelihood of sampling multiple binding modes. Protein regions with a high multiplicity of binding modes may serve as regulatory sites or hot-spots for structural transitions in the assembly. To facilitate the interpretation of the predictions, protein regions with different interaction behaviors can be visualised on protein structures generated by AlphaFold. The FuzPred web server (<ext-link xlink:href="https://fuzpred.bio.unipd.it" ext-link-type="uri">https://fuzpred.bio.unipd.it</ext-link>) thus offers insights into the structural and dynamical changes of proteins upon interactions and contributes to development of structure-function relationships under a variety of cellular conditions.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <caption>
            <p>FuzPred: a web server for the sequence-based prediction of the context-dependent binding modes of proteins.</p>
          </caption>
          <graphic xlink:href="gkad214figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>AIRC</institution>
            <institution-id institution-id-type="DOI">10.13039/501100005010</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>IG 26229</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>After the initial discovery of complexes formed by intrinsically disordered proteins, there is a recognition that proteins can sample a wide range of states in their bound forms, ranging from ordered to disordered assemblies (Figure <xref rid="F1" ref-type="fig">1</xref>) (<xref rid="B1" ref-type="bibr">1</xref>). Although disordered complexes were initially considered as non-specific or non-functional, ample experimental evidence based on biophysics, structure analysis, functional mutagenesis demonstrates that protein regions that remain conformationally heterogeneous in their specific complexes contribute to a wide-range of biological activities (<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B3" ref-type="bibr">3</xref>). Advances in structure determination techniques, in particular solution and single molecule methods, are enabling the characterisation of the conformational heterogeneity of disordered complexes (Figure <xref rid="F1" ref-type="fig">1</xref>) (<xref rid="B4" ref-type="bibr">4</xref>).</p>
    <fig position="float" id="F1">
      <label>Figure 1.</label>
      <caption>
        <p>Binding modes of protein interactions. Protein interactions sample a wide range of binding modes from ordered to disordered binding. The different binding modes are characterised by structural order or disorder in the bound state (horizontal bar), which are reflected by the heterogeneity of contact patterns. In ordered binding the contact patterns are well-defined, while in disordered binding they are heterogeneous, and in case of context-dependent binding, they can be either well-defined or variable depending on the cellular conditions. At the ends of the binding mode spectrum, proteins preferentially sample a unique binding mode, therefore the context dependence is weak. In the central region of the spectrum, protein regions can sample both ordered and disordered binding modes, so the context-dependence is high. Ordered binding is generated by a strong local sequence bias (blue), whereas disordered binding is due a weak sequence bias (orange). In context-dependent binding modes, the sequence bias is modulated by the conditions, and can be strong or weak depending on the context (green). Ordered binding modes, represented by the complex of merozoite surface protein 2 (blue, top left) from <italic toggle="yes">Plasmodium falciparum</italic> and the monoclonal antibody m6D8 (gray, PDB:4qxt (<xref rid="B41" ref-type="bibr">41</xref>)). Disordered binding is represented by the interactions between leukemia fusion protein AF9 (gray) and elongation factor AF4 (orange) (PDB:2lm0 (<xref rid="B42" ref-type="bibr">42</xref>), top right), where both partners retain considerable conformational heterogeneity in the bound complex. Context-dependent binding can be achieved by polymorphism, i.e. adopting different secondary structures upon binding such as in the case of ribosomal S6 kinase 1 (marine, slate, second to left) binding to S100b (gray, PDB:5csf, 5csi, 5csj (<xref rid="B43" ref-type="bibr">43</xref>)) or retaining conformational disorder in a condition-dependent manner such as in the case of p150 subunit of the eukaryotic initiation factor 4F (yellow) binding to the translation initiation factor 4E, (gray PDB: 1rf8 (<xref rid="B44" ref-type="bibr">44</xref>)).</p>
      </caption>
      <graphic xlink:href="gkad214fig1" position="float"/>
    </fig>
    <p>It is also becoming evident that different binding modes are associated with distinct biological functions. Disordered regions that undergo disorder-to-order transitions and adopt well-defined structures upon binding usually serve as recognition elements, which can be identified based on transient conformations in their unbound forms. For example, the tumor suppressor p53 binds to Mdm2 ubiquitin ligase through a short α-helical segment, which can also be observed in solution (Figure <xref rid="F1" ref-type="fig">1</xref>) (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>). Protein regions that remain to be heterogeneous in the bound state usually coordinate different activities or pathway components as well as organise higher-order assemblies (<xref rid="B7" ref-type="bibr">7</xref>). The formation and regulation of different kinds of higher-order protein structures, from amyloid fibrils to signaling assemblies and liquid-like condensates, are all associated with conformationally heterogeneous or fuzzy regions (<xref rid="B7" ref-type="bibr">7</xref>). For example, in the assembly of the AIM2 inflammasome, the linker region between the PYD and CARD domains serves as a switch to expose these domains for intermolecular interactions (<xref rid="B8" ref-type="bibr">8</xref>). The disorder-to-disorder binding mode provides a key contribution to protein phase separation (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>).</p>
    <p>The complexity of interactions is underscored by sampling multiplicity of binding modes under different cellular conditions. In particular, protein regions can be induced to adopt an ordered structure upon binding, while can also remain heterogeneous under different conditions (Figure <xref rid="F1" ref-type="fig">1</xref>). Actin polymerisation, for example, is assisted by WH2 domains, which remains partly disordered upon interactions (<xref rid="B11" ref-type="bibr">11</xref>). WH2 domains are anchored by a single salt bridge, the stability of which is modulated by ionic strength. High ion concentrations weaken the charge interactions and increase mobility, leading to the departure of WH2 domains and elongation of the actin chain (<xref rid="B12" ref-type="bibr">12</xref>). At low ionic strength, in contrast, the salt bridge stabilises the complex with the actin monomer leading to sequestration. Structural examples representing different binding modes can be found in the Protein Data Bank (PDB) (<xref rid="B13" ref-type="bibr">13</xref>).</p>
    <p>In this article, we describe the FuzPred web server (<ext-link xlink:href="https://fuzpred.bio.unipd.it" ext-link-type="uri">https://fuzpred.bio.unipd.it</ext-link>), which provides two key sequence-based predictions concerning the interaction behavior of proteins (Figure <xref rid="F1" ref-type="fig">1</xref>): (i) the probability to undergo disorder-to-order transition or disorder-to-disorder transitions and (ii) the likelihood of sampling a multiplicity of binding modes. The web server thus provides insights into the spectrum of interactions underlying the complex cellular behaviors of proteins.</p>
  </sec>
  <sec id="SEC2">
    <title>PREDICTION OF THE BINDING MODES OF PROTEINS</title>
    <sec id="SEC2-1">
      <title>Local sequence complexity determines the binding mode</title>
      <p>Analysis of over 2000 specific protein complexes showed that the degree of order upon binding is weakly correlated to the presence of secondary structure elements (<xref rid="B13" ref-type="bibr">13</xref>). Importantly, different binding modes are associated with distinct contact patterns. The disorder-to-order binding mode is associated with well-defined contacts, formed by residues with physico-chemical features distinct from their flanking residues (<xref rid="B13" ref-type="bibr">13</xref>). In contrast, disorder-to-disorder binding modes are characterised by heterogeneous, alternative contact patterns (<xref rid="B14" ref-type="bibr">14</xref>), formed by a set of residues that can establish chemically similar interactions. For example, highly polar and charged transcription factors can bind in shallow, hydrophobic clefts of their transactivators via multiple configurations, anchored by a few hydrophobic residues (<xref rid="B15" ref-type="bibr">15</xref>). The KIX domain of CREB-binding protein (CBP), for example, interacts with the kinase inducible domain (KID) of the cAMP response element binding protein CREB as well as in the interactions of cMyb transcription factor in disorder-to-disorder binding mode (<xref rid="B16" ref-type="bibr">16</xref>). In general, the binding modes reflect the entropy change upon binding, in particular disorder-to-order binding mode corresponds to decreasing entropy upon interactions. Therefore, the binding modes are applicable to both structured and disordered protein regions.</p>
      <p>We evaluate the local sequence composition of the interaction site, which determines the binding mode (<xref rid="B13" ref-type="bibr">13</xref>), based on the difference between the composition of the putative interacting motif and its flanking sequence, defined as a local sequence bias (Figure <xref rid="F1" ref-type="fig">1</xref>) (<xref rid="B13" ref-type="bibr">13</xref>). A few residues can generate a strong ordering bias in the binding site, leading to a well-defined structure and contact pattern. In contrast, similar residues or repetitive motifs can generate a weak bias leading to heterogeneous bound states, realised via a multiplicity of bound configurations and ambiguous contact patterns. These binding modes can be predicted based on the local sequence bias, which can be evaluated without considering a specific partner (<xref rid="B13" ref-type="bibr">13</xref>). The sequence bias is evaluated using a window of five to nine residues representing a putative binding region (Figure <xref rid="F2" ref-type="fig">2A</xref>). To this end, the differences in the frequencies of the 20 amino acids in the binding window are combined and compared to the 20-residue N- and C-terminal flanking sequences (<xref rid="B13" ref-type="bibr">13</xref>). Similarly, the sum of the differences in the Kyte–Doolittle hydrophobicity are computed for the same flanking regions. In addition, the difference in tendencies to form a well-defined or disordered structure are also evaluated. The method was trained using a logistic regression model with a scoring function comprising three terms derived from the differences between the binding window and its flanking sequence, as previously described in detail (<xref rid="B13" ref-type="bibr">13</xref>). The performance to discriminate between disorder-to-order and disorder-to-disorder binding modes was evaluated over 2000 protein complexes resulting in an area under the curve (AUC) of 0.85 using all PDB data, and 0.92 using protein regions, which are represented at least in three complexes (<xref rid="B13" ref-type="bibr">13</xref>).</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>Schematic representation of the multiplicity of binding modes (MBM) calculation. (<bold>A</bold>) Representation of the putative binding sites. The p53 (UniProt code: P04637) transactivation (TAD) region can interact through various binding sites, the size and precise location of which are not known a priori. To predict the binding features of residue W53, for example, we consider different possible binding sites with size varying between five and nine residues. The local sequence bias is determined for all possible binding sites (windows), at all possible locations involving W53 (left panel). (<bold>B</bold>) Binding mode distribution analysis. This procedure generates the distribution of disorder-to-order (blue, right top) and disorder-to-disorder (orange, right top) binding modes as computed from 35 p<sub>DO</sub> and p<sub>DD</sub> values. The median of such p<sub>DO</sub> and p<sub>DD</sub> distributions provides the most likely p<sub>DO</sub> and p<sub>DD</sub> value, based on which the binding mode can be assigned (<xref rid="B13" ref-type="bibr">13</xref>). According to these predictions, W53 is likely to undergo disorder-to-order transition upon binding. The information content of the p<sub>DO</sub> and p<sub>DD</sub> distributions, which can be computed as a Shannon entropy, informs on the likelihood to change the binding mode with the conditions (<xref rid="B18" ref-type="bibr">18</xref>). This is represented by the multiplicity of binding mode (MBM) graph shown on the right bottom, middle panel), where the Shannon entropy is normalised into [0,1] range (<xref rid="B14" ref-type="bibr">14</xref>). The MBM graph indicates that W53 likely changes binding modes and can possibly serve as an aggregation hot-spot.</p>
        </caption>
        <graphic xlink:href="gkad214fig2" position="float"/>
      </fig>
    </sec>
    <sec id="SEC2-2">
      <title>Evaluating the multiplicity of binding modes (MBM)</title>
      <p>Small variations in the location of the binding site can lead to considerable changes in the local bias (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B17" ref-type="bibr">17</xref>). These variations can be caused by post-translational modifications, availability of further binding partners, or the presence of co-factors, metabolites or ions. The impact of such variations on the binding mode can be evaluated using multiple potential binding sites with different length and position around the same residue (Figure <xref rid="F2" ref-type="fig">2A</xref>). This provides a distribution of binding modes, which are available for interactions of a given residue (Figure <xref rid="F2" ref-type="fig">2B</xref>) (<xref rid="B18" ref-type="bibr">18</xref>). The median of such distribution characterises the most likely binding mode for a given residue (<xref rid="B18" ref-type="bibr">18</xref>). The width of the distribution informs on the likelihood of sampling multiple binding modes. The MBM is quantified by the Shannon entropy computed from the binding mode distribution (Figure <xref rid="F2" ref-type="fig">2B</xref>) (<xref rid="B18" ref-type="bibr">18</xref>). The MBM characterises context-dependence, the predicted impact of the cellular environment on the binding mode (<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B20" ref-type="bibr">20</xref>). The FuzPred method performs AUC of over 0.90 in distinguishing context-dependent regions (CDR) from disorder-to-order and disorder-to-disorder regions using 750 protein complexes (<xref rid="B18" ref-type="bibr">18</xref>).</p>
    </sec>
    <sec id="SEC2-3">
      <title>The interaction behavior is represented by a binding mode landscape</title>
      <p>The binding mode landscape describes the interaction behavior of proteins by simultaneously characterising the binding mode and the MDM (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B20" ref-type="bibr">20</xref>). The x-axis displays the MBM and the y-axis displays the probability to form disordered interactions (Figure <xref rid="F3" ref-type="fig">3B</xref>). These two parameters inform on the most likely binding mode and its sensitivity to different partners or cellular conditions. Protein regions that usually remain heterogeneous in their assemblies are located at the upper part of the landscape. Protein regions that prefer undergoing disorder-to-order transitions are located at the lower part of the landscape. Protein regions that exhibit similar binding modes in a variety of conditions are located in the left part of the landscape, and protein regions that change their binding modes with the cellular conditions can be found in the right part of the landscape (Figure <xref rid="F3" ref-type="fig">3B</xref>).</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>FuzPred predictions of different interaction behaviors of p53. (<bold>A</bold>) Binding mode prediction. The binding modes are classified based on the probabilities of disorder-to-order (p<sub>DO</sub>, blue, graphs) and disorder-to-disorder transitions (p<sub>DD</sub>, orange graphs); and the multiplicity of binding modes (MBM, green). Disorder-to-order binding mode is represented by the p53 oligomerisation domain (PDB:1c26, 325–356 residues, top left), which has a high probability of disorder-to-order transition (p<sub>DO</sub>) and low multiplicity of binding modes, thus preferentially samples ordered binding modes as observed (329–341 residues magenta). Context-dependent binding modes (top middle) are represented by the p53 transactivation region in complex with the general transcription factor TFIIH (41–62 residues, PDB:2ruk) and in complex HMGB1 (1–93 residues, PDB: 2ly4). The interacting regions (green: 49–55 residues, and blue: 56–60 residues) are predicted to have high MBM values, and a considerable probability to sample both ordered and disordered interactions. The disorder-to-disorder binding mode can be represented the p53 transactivator region (2–61 residues, PDB:5phd, top right) in complex with the TAZ2 domain of the CBP/p300 coactivator, through a short peptide motif (2–14 residues, teal) exhibiting high p<sub>DD</sub> and low MBM values, in accord with the observed conformational heterogeneity. (<bold>B</bold>) The binding mode landscape characterises the interaction behavior. The binding mode landscape represents the binding mode (p<sub>DD</sub>, y axis) together with its variability, as characterised by MBM (x-axis). The lower left quadrant (<italic toggle="yes">p</italic><sub>DD</sub>&lt; 0.40; MBM &lt; 0.55, red circles) represents the classical view of binding, with preferentially ordered interfaces, as represented by the p53 oligomerisation domain (PDB:1c26). The upper left quadrant (<italic toggle="yes">p</italic><sub>DD</sub>≥ 0.60; MBM &lt; 0.55, cyan pentagons) represents preferentially heterogeneous complexes, as represented by the p53 complex with TAZ2 of CBP/p300 (PDB:5phd). The lower right quadrant (<italic toggle="yes">p</italic><sub>DD</sub>&lt; 0.40; MBM ≥ 0.65, light blue triangles) represents polymorphic regions that form different structures in a context-dependent manner, for example amylogenic regions (<xref rid="B45" ref-type="bibr">45</xref>). The upper right quadrant (<italic toggle="yes">p</italic><sub>DD</sub>≥ 0.60; MBM ≥ 0.65, green squares) represents disordered binding regions that can conditionally convert from disordered to ordered binding modes, like in case of aggregation hot-spots (<xref rid="B21" ref-type="bibr">21</xref>). Context-dependent binding modes are shown in the right part of the landscape, represented by 49–55 residues interacting with general transcription factor TFIIH (PDB:2ruk, green squares) and 56–60 residues interacting with HMGB1 (PDB: 2ly4, blue triangles). The more stable binding modes have low MBM values and can be found in the left part of the binding mode landscape. These include the disorder-to-order binding mode, represented by the 329–341 residues of the oligomerisation domain (PDB:1c26, magenta circles), and the disorder-to-disorder binding mode represented by the 2–14 residues in complex with with the TAZ2 domain of the CBP/p300 coactivator (PDB:5phd, cyan pentagons).</p>
        </caption>
        <graphic xlink:href="gkad214fig3" position="float"/>
      </fig>
      <p>The regions that form disordered complexes with a variety of partners (upper left quadrant) often drive protein phase separation (<xref rid="B9" ref-type="bibr">9</xref>). In contrast, regions which tend form disordered assemblies, but can be induced to form ordered structures can be found at the upper right quadrant (<xref rid="B21" ref-type="bibr">21</xref>). These regions often serve as hot-spots of aggregation (<xref rid="B22" ref-type="bibr">22</xref>). Regions in the lower right quadrant may undergo disorder-to-order transitions upon binding, but can form polymorphic structures. These are typically the regions serving as amyloid cores (<xref rid="B22" ref-type="bibr">22</xref>). Finally, the regions in the lower left quadrant are regions that adopt a well-defined structure upon binding with all their interaction partners.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Predicted interaction characteristics available from the FuzPred web server</title>
      <p>All predictions are based on solely the protein sequence, which can be provided for the input as a UniProt code (<xref rid="B23" ref-type="bibr">23</xref>) or the FASTA file (Figure <xref rid="F4" ref-type="fig">4A</xref>). Importantly, no information on the partner identity is required. The results are displayed on a separate page.</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>FuzPred server Input (<bold>A</bold>) and Result's (B–E) pages. The usage of the FuzPred server is illustrated using the sequence of the p53 tumor suppressor. (A) Input page. The input can be specified by the gene or UniProt identifier (P04637). Alternatively, the sequence can be provided, using only standard amino acids. In case of modified sequence, the cross-links with other databases, such as UniProt, Pfam will not be displayed on the Results page. (<bold>B</bold>) Prediction of binding mode and multiplicity of binding modes. The user may choose from the upper tabs to display the residue-specific probabilities of disorder-to-order (p<sub>DO</sub>, left) or disorder-to-disorder (p<sub>DD</sub>, right) transitions. In both cases, the multiplicity of binding modes (MBM) is displayed below. This graph, reflecting context-dependence of the interactions, does not depend on the binding mode analyzed. Regions undergoing disorder-to-order (left, blue) or disorder-to-disorder transitions (right, orange) are displayed under the MBM graph. In both cases, context-dependent regions (MBM ≥ 0.65, light green) and disordered regions by the Espritz algorithm (light brown) are also shown. (<bold>C</bold>) Binding mode landscape. The binding mode (y-axis: disorder-to-order, left; disorder-to-disorder, right) is displayed as a function of the likelihood of changing the binding mode (x-axis: multiplicity of binding modes, MBM). The characteristics of the four regions of the landscape are labelled, the grey areas have mixed (intermediate) properties. (<bold>D</bold>) Protein information. Cross-links to experimental databases of protein disorder and liquid-liquid phase separation, and sites of posttranslational modifications. (<bold>E</bold>) Visualisation of regions with different interaction characteristics. The disorder-to-order (left, blue), the disorder-to-disorder (orange, right) and the context-dependent (green, middle) are displayed on structured generated by AlphaFold.</p>
        </caption>
        <graphic xlink:href="gkad214fig4" position="float"/>
      </fig>
    </sec>
    <sec id="SEC2-5">
      <title>Prediction of the binding mode</title>
      <p>The binding mode is characterised by the disorder-to-order or disorder-to-disorder transitions upon binding. The user can choose the type of structural transition using the two tabs on the top of the page (Figure <xref rid="F4" ref-type="fig">4B</xref>). Disorder-to-order transitions characterises the sequence based probability of ordering upon binding (<italic toggle="yes">p</italic><sub>DO</sub>, blue) (Figure <xref rid="F4" ref-type="fig">4B</xref>). In case of disordered proteins, regions with <italic toggle="yes">p</italic><sub>DO</sub> ≥ 0.6 likely adopt a folded structure upon binding. In case of ordered proteins, regions with <italic toggle="yes">p</italic><sub>DO</sub> ≥ 0.6 rigidify upon binding. Disorder-to-disorder transitions characterises the sequence based probability of decreasing order upon binding (<italic toggle="yes">p</italic><sub>DD</sub>, orange) (Figure <xref rid="F4" ref-type="fig">4B</xref>). Protein regions with <italic toggle="yes">p</italic><sub>DD</sub> ≥ 0.6 are likely remain or become heterogeneous conformational ensemble in the bound assembly. Folded proteins regions with <italic toggle="yes">p</italic><sub>DD</sub> ≥ 0.6 may unfold upon interactions. Protein regions with <italic toggle="yes">p</italic><sub>DO</sub> and <italic toggle="yes">p</italic><sub>DD</sub> in the range of 0.4–0.6 usually can sample both binding modes.</p>
      <p>The graphs displaying the probabilities of disorder-to-order or disorder-to-disorder transitions are interactive (Figure <xref rid="F4" ref-type="fig">4B</xref>). Moving the cursor above the columns the graph show the <italic toggle="yes">p</italic><sub>DO</sub> or <italic toggle="yes">p</italic><sub>DD</sub> values belonging to each data point, and the identity the given residue. One can also zoom on selected regions of interest.</p>
    </sec>
    <sec id="SEC2-6">
      <title>Prediction of the multiplicity of binding modes (MBM)</title>
      <p>The likelihood that a protein region samples multiple binding modes under different cellular conditions is shown in the second panel below the graphs on the binding mode predictions (Figure <xref rid="F4" ref-type="fig">4B</xref>). The MBM value is derived from the Shannon entropy computed from the binding mode distributions in the presence of a series of hypothetical partners (<xref rid="B21" ref-type="bibr">21</xref>), normalised into the range of [0,1] (<xref rid="B14" ref-type="bibr">14</xref>). Protein regions with MBM ≥0.65 are sensitive to the cellular context and are expected to sample multiple binding modes (<xref rid="B21" ref-type="bibr">21</xref>). Protein regions with MBM &lt; 0.55 likely sample one binding mode. The MBM graph is interactive (Figure <xref rid="F4" ref-type="fig">4B</xref>) showing the identity of residues and the corresponding MBM values. The MBM graph is identical for the disorder-to-order or disorder-to-disorder transitions.</p>
    </sec>
    <sec id="SEC2-7">
      <title>Identification of protein regions with different interaction behaviors</title>
      <p>Protein regions with particular interaction characteristics are defined below the binding mode and MBM graphs (Figure <xref rid="F4" ref-type="fig">4B</xref>). At least five consecutive amino acid residues with the same property are considered as a region, which is represented by a bar, with the same color as the corresponding graph. Disorder-to-order regions (DORs) are defined as <italic toggle="yes">p<sub>DO</sub></italic> ≥ 0.6 (blue), disorder-to-disorder regions (DDRs) as <italic toggle="yes">p</italic><sub>DD</sub> ≥ 0.6 (orange). Context-dependent regions, defined as MBM ≥ 0.65. In addition, protein regions, predicted to be disordered (Espritz score ≥ 0.3085 (<xref rid="B24" ref-type="bibr">24</xref>)) in the unbound form are also shown. The boundaries of the regions are displayed above the bars as well as shown by moving the cursor above them.</p>
    </sec>
    <sec id="SEC2-8">
      <title>Binding mode landscape</title>
      <p>The residue-specific interaction behaviors are shown on the binding mode landscape, which simultaneously displays the binding mode (y-axis) and the MBM, the multiplicity of binding modes (x-axis), which can be sampled in different cellular environments (Figure <xref rid="F4" ref-type="fig">4C</xref>). The MBM values are normalised into the range of [0,1]. All residues are represented by symbols and their identity is shown by moving the cursor above the symbols. The graph is divided into four sections, corresponding to different interaction behaviors (Figure <xref rid="F4" ref-type="fig">4C</xref>). The lower left quadrant corresponds to structured interaction elements that rigidify or adopt structure upon binding (low <italic toggle="yes">p</italic><sub>DD</sub>, high <italic toggle="yes">p</italic><sub>DO</sub>, low MBM). The upper left quadrant corresponds to protein regions that remain to be disordered under a wide variety of cellular conditions and partners (high <italic toggle="yes">p</italic><sub>DD</sub>, low <italic toggle="yes">p</italic><sub>DO</sub>, low MBM). These regions are distinguished in protein phase separation (<xref rid="B9" ref-type="bibr">9</xref>). The lower right quadrant displays the structured, polymorphic interaction elements (low <italic toggle="yes">p</italic><sub>DD</sub>, high <italic toggle="yes">p</italic><sub>DO</sub>, high MBM), for example amylogenic regions (<xref rid="B22" ref-type="bibr">22</xref>). The upper right quadrant shows those residues that dominantly sample disordered binding configurations, but can also be triggered to ordered bound states (high <italic toggle="yes">p</italic><sub>DD</sub>, low <italic toggle="yes">p</italic><sub>DO</sub>, high MBM). These residues are hot-spots for aggregation (<xref rid="B22" ref-type="bibr">22</xref>). The boundaries of the regions are marked by gray. Protein regions falling into the borderlines usually exhibit a mixture of behaviors.</p>
    </sec>
    <sec id="SEC2-9">
      <title>Sequence features and cross-links to other databases</title>
      <p>The FuzPred server provides information on some sequence features that may be relevant to regulate binding characteristics. In this panel, the sequence corresponding to the UniProt code or the sequence provided is shown (<xref rid="B25" ref-type="bibr">25</xref>). Below the experimentally observed fuzzy regions, with validated functional impacts are displayed as derived from the FuzDB, the database of fuzzy interactions (<xref rid="B4" ref-type="bibr">4</xref>). Below post-translational modification sites (PTMs) derived from UniProt database are displayed by red dots (<xref rid="B26" ref-type="bibr">26</xref>). Positioning the cursor above the symbols will display the modified residue, the PTM type and the modifying enzyme. Evolutionary conserved protein domains, which are derived from the Pfam database (<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>), are shown in the last row (Figure <xref rid="F4" ref-type="fig">4D</xref>).</p>
      <p>Crosslinks to experimental databases, such as on protein disorder (DisProt (<xref rid="B29" ref-type="bibr">29</xref>)), protein structural ensembles (PED (<xref rid="B30" ref-type="bibr">30</xref>)) and fuzzy interactions (FuzDB (<xref rid="B4" ref-type="bibr">4</xref>)) are provided below. As protein regions with disorder-to-disorder binding modes are distinguished in protein liquid-liquid phase separation (<xref rid="B9" ref-type="bibr">9</xref>), cross-links to PhaSepDB (<xref rid="B31" ref-type="bibr">31</xref>), LLPSDB (<xref rid="B32" ref-type="bibr">32</xref>) and PhaSePro (<xref rid="B33" ref-type="bibr">33</xref>) databases of liquid-liquid phase separation are displayed.</p>
    </sec>
    <sec id="SEC2-10">
      <title>Graphical representation of disorder-to-order, disorder-to-disorder and context-dependent regions</title>
      <p>Protein regions with different interaction characteristics are visualised by Mol* (<xref rid="B34" ref-type="bibr">34</xref>) on the structures predicted by AlphaFold (<xref rid="B35" ref-type="bibr">35</xref>) (AF, Figure <xref rid="F4" ref-type="fig">4E</xref>), which are accessed by using 3D-Beacons network (<xref rid="B36" ref-type="bibr">36</xref>). Disorder-to-order regions are shown in blue and disorder-to-disorder regions in orange and context-dependent regions (MBM ≥ 0.65) in green (Figure <xref rid="F4" ref-type="fig">4E</xref>). In case the predicted structure is not available in the AlphaFold database (<xref rid="B37" ref-type="bibr">37</xref>), the user may carry out the structure predictions for the given sequence in a separate window (Figure <xref rid="F4" ref-type="fig">4E</xref>) through AlphaFold Colab provided by DeepMind and Google (<xref rid="B38" ref-type="bibr">38</xref>). The coordinates derived from the AlphaFold predictions (<xref rid="B35" ref-type="bibr">35</xref>), can then be uploaded to visualise the interaction properties estimated by FuzPred (Figure <xref rid="F4" ref-type="fig">4E</xref>). The AlphaFold structures show disordered regions as extended chains, which may significantly deviate from in particular in their bound states (<xref rid="B39" ref-type="bibr">39</xref>).</p>
    </sec>
    <sec id="SEC2-11">
      <title>Download options</title>
      <p>The FuzPred prediction results, the residue-based <italic toggle="yes">p</italic><sub>DO</sub>, <italic toggle="yes">p</italic><sub>DD</sub> and MBM values can be downloaded in .tsv format via the ‘Download’ tab on the top right of the page. The coordinates of the disorder-to-order, disorder-to-disorder regions and context-dependent regions can also be downloaded in .tsv format via the ‘Download’ tab on the top right of the page. The graph displaying the <italic toggle="yes">p</italic><sub>DO</sub>, <italic toggle="yes">p</italic><sub>DD</sub> and MBM values together with the bar representation of the different interacting regions can be saved as an image by the camera icon below the ‘Download’ tab on the top of the page</p>
      <p>A snapshot of the the colored AlphaFold structures representing protein regions of different interaction behaviors can be generated using the ‘Screenshot’ tab above the image, and the coordinates of the predicted structure can be downloaded. This option is useful for further graphical analysis including other features, for example posttranslational modification sites.</p>
    </sec>
    <sec id="SEC2-12">
      <title>Tutorial page and references</title>
      <p>The Tutorial provides a detailed description of the results, which are shown in the results page. This page is organised similarly to the above sections of the article. On the right side a navigator bar facilitates orientation on the page. The References assembles the literature on fuzziness, organised in a thematic manner. A cross-link to the FuzDrop server (<ext-link xlink:href="http://fuzdrop.bio.unipd.it" ext-link-type="uri">http://fuzdrop.bio.unipd.it</ext-link>) (<xref rid="B40" ref-type="bibr">40</xref>) is provided to further explore the liquid-liquid phase separation characteristics of the protein.</p>
    </sec>
    <sec id="SEC2-13">
      <title>FuzPred server application areas</title>
      <p>The FuzPred server has four main application areas, describing different interaction behaviors (Table <xref rid="tbl1" ref-type="table">1</xref>).</p>
      <list list-type="order">
        <list-item>
          <p><bold><italic toggle="yes">Identification of the binding modes of protein regions</italic>.</bold> The probabilities of the disorder-to-order (<italic toggle="yes">p</italic><sub>DO</sub>) and disorder-to-disorder (<italic toggle="yes">p</italic><sub>DO</sub>) transitions inform on the binding elements that adopt a well-defined structure upon binding and those that remain to be heterogeneous in the specific assembly.</p>
        </list-item>
        <list-item>
          <p><bold><italic toggle="yes">Identification of protein regions with multiplicity of binding modes</italic>.</bold> The MBM values inform on the likelihood of sampling multiple binding modes under different cellular conditions. Context-sensitive residues can exhibit both ordered or disordered binding modes and can for example serve as posttranslational modification sites.</p>
        </list-item>
        <list-item>
          <p><bold><italic toggle="yes">Identification of interaction behaviors: polymorphic regions and dynamic regulatory regions</italic>.</bold>Residues with high MBM and <italic toggle="yes">p</italic><sub>DO</sub> values can sample different ordered conformations and exhibit polymorphism in their complexes. Residues with high MBM and <italic toggle="yes">p</italic><sub>DD</sub> values are dominantly disordered, and can be induced to be ordered to form transient contact sites.</p>
        </list-item>
        <list-item>
          <p><bold><italic toggle="yes">Identification of mutations inducing aggregation</italic>.</bold> Mutations that cause protein aggregation can induce either unfolding (deposition) or maturation of condensates (condensation). In the first case the mutation will shift the position in the binding landscape along the diagonal, whereas in the second case, the shift will be horizontal to the right, possibly in the lower part of the binding landscape.</p>
        </list-item>
      </list>
      <table-wrap position="float" id="tbl1">
        <label>Table 1.</label>
        <caption>
          <p>Application areas of the FuzPred web server</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Problem</th>
              <th rowspan="1" colspan="1">Parameter, threshold</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Identification of recognition elements of disordered proteins</td>
              <td rowspan="1" colspan="1"><italic toggle="yes">p</italic><sub>DO</sub>≥ 0.60</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Identification of protein regions forming fuzzy complexes</td>
              <td rowspan="1" colspan="1"><italic toggle="yes">p</italic><sub>DD</sub>≥ 0.60</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Identification of context-dependent interaction sites (e.g. post-translational modification site)</td>
              <td rowspan="1" colspan="1">MBM≥ 0.65</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Identification of regions that can partition into protein condensates</td>
              <td rowspan="1" colspan="1"><italic toggle="yes">p</italic><sub>DD</sub>≥ 0.60</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Identification of aggregation hot-spots within protein condensates</td>
              <td rowspan="1" colspan="1"><italic toggle="yes">p</italic><sub>DD</sub>≥ 0.60; MBM ≥ 0.65</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC3">
    <title>CONCLUSIONS</title>
    <p>It is increasingly recognised that proteins exhibit complex interaction behaviors in cells by sampling a wide range of binding modes from ordered to disordered bound states, which may vary depending on the cellular conditions. The FuzPred web server provides a comprehensive description of the interaction behaviors by predicting both the binding mode and the multiplicity of binding modes without the need of specifying the binding partner. Thus, the FuzPred web server identifies regions that are dominantly structured or disordered in their complexes as well as context-sensitive sites that alternate between these binding modes. Such analysis, and the representation of the results on the structures predicted by AlphaFold, enables the identification of molecular recognition or regulatory sites as well as segments of proteins driving higher-order assemblies. The residue-based probabilities enable the analysis of mutants, and elucidating the impact of disease-associated mutations on protein interactions.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC4">
    <title>DATA AVAILABILITY</title>
    <p>The authors confirm that the data in the article are publicly available.</p>
  </sec>
</body>
<back>
  <sec id="SEC5">
    <title>FUNDING</title>
    <p>AIRC [IG 26229 to M.F.]. Funding for open access charge: AIRC [IG 26229].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>Fuzziness in protein interactions –a historical perspective</article-title>. <source>J. Mol. Biol.</source><year>2018</year>; <volume>430</volume>:<fpage>2278</fpage>–<lpage>2287</lpage>.<pub-id pub-id-type="pmid">29477337</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tompa</surname><given-names>P.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions</article-title>. <source>Trends Biochem. Sci.</source><year>2008</year>; <volume>33</volume>:<fpage>2</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">18054235</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miskei</surname><given-names>M.</given-names></string-name>, <string-name><surname>Antal</surname><given-names>C.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>FuzDB: database of fuzzy complexes, a tool to develop stochastic structure–function relationships for protein complexes and higher-order assemblies</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>D228</fpage>–<lpage>D235</lpage>.<pub-id pub-id-type="pmid">27794553</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hatos</surname><given-names>A.</given-names></string-name>, <string-name><surname>Monzon</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Tosatto</surname><given-names>S.C.E.</given-names></string-name>, <string-name><surname>Piovesan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>FuzDB: a new phase in understanding fuzzy interactions</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D509</fpage>–<lpage>D517</lpage>.<pub-id pub-id-type="pmid">34791357</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kussie</surname><given-names>P.H.</given-names></string-name>, <string-name><surname>Gorina</surname><given-names>S.</given-names></string-name>, <string-name><surname>Marechal</surname><given-names>V.</given-names></string-name>, <string-name><surname>Elenbaas</surname><given-names>B.</given-names></string-name>, <string-name><surname>Moreau</surname><given-names>J.</given-names></string-name>, <string-name><surname>Levine</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Pavletich</surname><given-names>N.P.</given-names></string-name></person-group><article-title>Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</article-title>. <source>Science</source>. <year>1996</year>; <volume>274</volume>:<fpage>948</fpage>–<lpage>953</lpage>.<pub-id pub-id-type="pmid">8875929</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vise</surname><given-names>P.D.</given-names></string-name>, <string-name><surname>Baral</surname><given-names>B.</given-names></string-name>, <string-name><surname>Latos</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Daughdrill</surname><given-names>G.W.</given-names></string-name></person-group><article-title>NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain</article-title>. <source>Nucleic Acids Res.</source><year>2005</year>; <volume>33</volume>:<fpage>2061</fpage>–<lpage>2077</lpage>.<pub-id pub-id-type="pmid">15824059</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>The structure and dynamics of higher-order assemblies: amyloids, signalosomes, and granules</article-title>. <source>Cell</source>. <year>2016</year>; <volume>165</volume>:<fpage>1055</fpage>–<lpage>1066</lpage>.<pub-id pub-id-type="pmid">27203110</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>A.</given-names></string-name>, <string-name><surname>Magupalli</surname><given-names>V.G.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Atianand</surname><given-names>M.K.</given-names></string-name>, <string-name><surname>Vos</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Schroder</surname><given-names>G.F.</given-names></string-name>, <string-name><surname>Fitzgerald</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Egelman</surname><given-names>E.H.</given-names></string-name></person-group><article-title>Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes</article-title>. <source>Cell</source>. <year>2014</year>; <volume>156</volume>:<fpage>1193</fpage>–<lpage>1206</lpage>.<pub-id pub-id-type="pmid">24630722</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hardenberg</surname><given-names>M.</given-names></string-name>, <string-name><surname>Horvath</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ambrus</surname><given-names>V.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name>, <string-name><surname>Vendruscolo</surname><given-names>M.</given-names></string-name></person-group><article-title>Widespread occurrence of the droplet state of proteins in the human proteome</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2020</year>; <volume>117</volume>:<fpage>33254</fpage>–<lpage>33262</lpage>.<pub-id pub-id-type="pmid">33318217</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name>, <string-name><surname>Vendruscolo</surname><given-names>M.</given-names></string-name></person-group><article-title>Generic nature of the condensed states of proteins</article-title>. <source>Nat. Cell Biol.</source><year>2021</year>; <volume>23</volume>:<fpage>587</fpage>–<lpage>594</lpage>.<pub-id pub-id-type="pmid">34108660</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Renault</surname><given-names>L.</given-names></string-name>, <string-name><surname>Bugyi</surname><given-names>B.</given-names></string-name>, <string-name><surname>Carlier</surname><given-names>M.F.</given-names></string-name></person-group><article-title>Spire and Cordon-bleu: multifunctional regulators of actin dynamics</article-title>. <source>Trends Cell Biol.</source><year>2008</year>; <volume>18</volume>:<fpage>494</fpage>–<lpage>504</lpage>.<pub-id pub-id-type="pmid">18774717</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Didry</surname><given-names>D.</given-names></string-name>, <string-name><surname>Cantrelle</surname><given-names>F.X.</given-names></string-name>, <string-name><surname>Husson</surname><given-names>C.</given-names></string-name>, <string-name><surname>Roblin</surname><given-names>P.</given-names></string-name>, <string-name><surname>Moorthy</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Perez</surname><given-names>J.</given-names></string-name>, <string-name><surname>Le Clainche</surname><given-names>C.</given-names></string-name>, <string-name><surname>Hertzog</surname><given-names>M.</given-names></string-name>, <string-name><surname>Guittet</surname><given-names>E.</given-names></string-name>, <string-name><surname>Carlier</surname><given-names>M.F.</given-names></string-name><etal>et al</etal>.</person-group><article-title>How a single residue in individual beta-thymosin/WH2 domains controls their functions in actin assembly</article-title>. <source>EMBO J.</source><year>2012</year>; <volume>31</volume>:<fpage>1000</fpage>–<lpage>1013</lpage>.<pub-id pub-id-type="pmid">22193718</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miskei</surname><given-names>M.</given-names></string-name>, <string-name><surname>Horvath</surname><given-names>A.</given-names></string-name>, <string-name><surname>Vendruscolo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>Sequence-based prediction of fuzzy protein interactions</article-title>. <source>J. Mol. Biol.</source><year>2020</year>; <volume>432</volume>:<fpage>2289</fpage>–<lpage>2303</lpage>.<pub-id pub-id-type="pmid">32112804</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barrera-Vilarmau</surname><given-names>S.</given-names></string-name>, <string-name><surname>Teixeira</surname><given-names>J.M.C.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>Protein interactions: anything new?</article-title>. <source>Essays Biochem.</source><year>2022</year>; <volume>66</volume>:<fpage>821</fpage>–<lpage>830</lpage>.<pub-id pub-id-type="pmid">36416856</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brzovic</surname><given-names>P.S.</given-names></string-name>, <string-name><surname>Heikaus</surname><given-names>C.C.</given-names></string-name>, <string-name><surname>Kisselev</surname><given-names>L.</given-names></string-name>, <string-name><surname>Vernon</surname><given-names>R.</given-names></string-name>, <string-name><surname>Herbig</surname><given-names>E.</given-names></string-name>, <string-name><surname>Pacheco</surname><given-names>D.</given-names></string-name>, <string-name><surname>Warfield</surname><given-names>L.</given-names></string-name>, <string-name><surname>Littlefield</surname><given-names>P.</given-names></string-name>, <string-name><surname>Baker</surname><given-names>D.</given-names></string-name>, <string-name><surname>Klevit</surname><given-names>R.E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The acidic transcription activator Gcn4 binds the mediator subunit Gal11/Med15 using a simple protein interface forming a fuzzy complex</article-title>. <source>Mol. Cell</source>. <year>2011</year>; <volume>44</volume>:<fpage>942</fpage>–<lpage>953</lpage>.<pub-id pub-id-type="pmid">22195967</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zor</surname><given-names>T.</given-names></string-name>, <string-name><surname>Mayr</surname><given-names>B.M.</given-names></string-name>, <string-name><surname>Dyson</surname><given-names>H.J.</given-names></string-name>, <string-name><surname>Montminy</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>P.E.</given-names></string-name></person-group><article-title>Roles of phosphorylation and helix propensity in the binding of the KIX domain of CREB-binding protein by constitutive (c-Myb) and inducible (CREB) activators</article-title>. <source>J. Biol. Chem.</source><year>2002</year>; <volume>277</volume>:<fpage>42241</fpage>–<lpage>42248</lpage>.<pub-id pub-id-type="pmid">12196545</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>Classifying the binding modes of disordered proteins</article-title>. <source>Int. J. Mol. Sci.</source><year>2020</year>; <volume>21</volume>:<fpage>8615</fpage>.<pub-id pub-id-type="pmid">33207556</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Horvath</surname><given-names>A.</given-names></string-name>, <string-name><surname>Miskei</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ambrus</surname><given-names>V.</given-names></string-name>, <string-name><surname>Vendruscolo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>Sequence-based prediction of protein binding mode landscapes</article-title>. <source>PLoS Comput. Biol.</source><year>2020</year>; <volume>16</volume>:<fpage>e1007864</fpage>.<pub-id pub-id-type="pmid">32453748</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>Towards a stochastic paradigm: from fuzzy ensembles to cellular functions</article-title>. <source>Molecules</source>. <year>2018</year>; <volume>23</volume>:<fpage>3008</fpage>.<pub-id pub-id-type="pmid">30453632</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vendruscolo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>Protein condensation diseases: therapeutic opportunities</article-title>. <source>Nat. Commun.</source><year>2022</year>; <volume>13</volume>:<fpage>5550</fpage>.<pub-id pub-id-type="pmid">36138006</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Horvath</surname><given-names>A.</given-names></string-name>, <string-name><surname>Vendruscolo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>Sequence-based prediction of the cellular toxicity associated with amyloid aggregation within protein condensates</article-title>. <source>Biochemistry</source>. <year>2022</year>; <volume>61</volume>:<fpage>2461</fpage>–<lpage>2469</lpage>.<pub-id pub-id-type="pmid">36341999</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vendruscolo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>Sequence determinants of the aggregation of proteins within condensates generated by liquid-liquid phase separation</article-title>. <source>J. Mol. Biol.</source><year>2021</year>; <volume>434</volume>:<fpage>167201</fpage>.<pub-id pub-id-type="pmid">34391803</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>UniProt</surname><given-names>C.</given-names></string-name></person-group><article-title>UniProt: the universal protein knowledgebase in 2021</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D480</fpage>–<lpage>D489</lpage>.<pub-id pub-id-type="pmid">33237286</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Walsh</surname><given-names>I.</given-names></string-name>, <string-name><surname>Martin</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Di Domenico</surname><given-names>T.</given-names></string-name>, <string-name><surname>Tosatto</surname><given-names>S.C.</given-names></string-name></person-group><article-title>ESpritz: accurate and fast prediction of protein disorder</article-title>. <source>Bioinformatics</source>. <year>2012</year>; <volume>28</volume>:<fpage>503</fpage>–<lpage>509</lpage>.<pub-id pub-id-type="pmid">22190692</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bevilacqua</surname><given-names>M.</given-names></string-name>, <string-name><surname>Paladin</surname><given-names>L.</given-names></string-name>, <string-name><surname>Tosatto</surname><given-names>S.C.E.</given-names></string-name>, <string-name><surname>Piovesan</surname><given-names>D</given-names></string-name></person-group><article-title>ProSeqViewer: an interactive, responsive and efficient TypeScript library for visualization of sequences and alignments in web applications</article-title>. <source>Bioinformatics</source>. <year>2022</year>; <volume>38</volume>:<fpage>1129</fpage>–<lpage>1130</lpage>.<pub-id pub-id-type="pmid">34788797</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Paladin</surname><given-names>L.</given-names></string-name>, <string-name><surname>Schaeffer</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gaudet</surname><given-names>P.</given-names></string-name>, <string-name><surname>Zahn-Zabal</surname><given-names>M.</given-names></string-name>, <string-name><surname>Michel</surname><given-names>P.A.</given-names></string-name>, <string-name><surname>Piovesan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Tosatto</surname><given-names>S.C.E.</given-names></string-name>, <string-name><surname>Bairoch</surname><given-names>A.</given-names></string-name></person-group><article-title>The Feature-Viewer: a visualization tool for positional annotations on a sequence</article-title>. <source>Bioinformatics</source>. <year>2020</year>; <volume>36</volume>:<fpage>3244</fpage>–<lpage>3245</lpage>.<pub-id pub-id-type="pmid">31985787</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mistry</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chuguransky</surname><given-names>S.</given-names></string-name>, <string-name><surname>Williams</surname><given-names>L.</given-names></string-name>, <string-name><surname>Qureshi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Salazar</surname><given-names>G.A.</given-names></string-name>, <string-name><surname>Sonnhammer</surname><given-names>E.L.L.</given-names></string-name>, <string-name><surname>Tosatto</surname><given-names>S.C.E.</given-names></string-name>, <string-name><surname>Paladin</surname><given-names>L.</given-names></string-name>, <string-name><surname>Raj</surname><given-names>S.</given-names></string-name>, <string-name><surname>Richardson</surname><given-names>L.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Pfam: the protein families database in 2021</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D412</fpage>–<lpage>D419</lpage>.<pub-id pub-id-type="pmid">33125078</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Paysan-Lafosse</surname><given-names>T.</given-names></string-name>, <string-name><surname>Blum</surname><given-names>M.</given-names></string-name>, <string-name><surname>Chuguransky</surname><given-names>S.</given-names></string-name>, <string-name><surname>Grego</surname><given-names>T.</given-names></string-name>, <string-name><surname>Pinto</surname><given-names>B.L.</given-names></string-name>, <string-name><surname>Salazar</surname><given-names>G.A.</given-names></string-name>, <string-name><surname>Bileschi</surname><given-names>M.L.</given-names></string-name>, <string-name><surname>Bork</surname><given-names>P.</given-names></string-name>, <string-name><surname>Bridge</surname><given-names>A.</given-names></string-name>, <string-name><surname>Colwell</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>InterPro in 2022</article-title>. <source>Nucleic Acids Res.</source><year>2023</year>; <volume>51</volume>:<fpage>D418</fpage>–<lpage>D427</lpage>.<pub-id pub-id-type="pmid">36350672</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hatos</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hajdu-Soltesz</surname><given-names>B.</given-names></string-name>, <string-name><surname>Monzon</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Palopoli</surname><given-names>N.</given-names></string-name>, <string-name><surname>Alvarez</surname><given-names>L.</given-names></string-name>, <string-name><surname>Aykac-Fas</surname><given-names>B.</given-names></string-name>, <string-name><surname>Bassot</surname><given-names>C.</given-names></string-name>, <string-name><surname>Benitez</surname><given-names>G.I.</given-names></string-name>, <string-name><surname>Bevilacqua</surname><given-names>M.</given-names></string-name>, <string-name><surname>Chasapi</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>DisProt: intrinsic protein disorder annotation in 2020</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D269</fpage>–<lpage>D276</lpage>.<pub-id pub-id-type="pmid">31713636</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lazar</surname><given-names>T.</given-names></string-name>, <string-name><surname>Martinez-Perez</surname><given-names>E.</given-names></string-name>, <string-name><surname>Quaglia</surname><given-names>F.</given-names></string-name>, <string-name><surname>Hatos</surname><given-names>A.</given-names></string-name>, <string-name><surname>Chemes</surname><given-names>L.B.</given-names></string-name>, <string-name><surname>Iserte</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Mendez</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Garrone</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Saldano</surname><given-names>T.E.</given-names></string-name>, <string-name><surname>Marchetti</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>PED in 2021: a major update of the protein ensemble database for intrinsically disordered proteins</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D404</fpage>–<lpage>D411</lpage>.<pub-id pub-id-type="pmid">33305318</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hou</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>T.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>P.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>X.</given-names></string-name>, <string-name><surname>You</surname><given-names>K.</given-names></string-name>, <string-name><surname>Li</surname><given-names>T.</given-names></string-name></person-group><article-title>PhaSepDB in 2022: annotating phase separation-related proteins with droplet states, co-phase separation partners and other experimental information</article-title>. <source>Nucleic Acids Res.</source><year>2023</year>; <volume>51</volume>:<fpage>D460</fpage>–<lpage>D465</lpage>.<pub-id pub-id-type="pmid">36124686</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Peng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Tang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Qi</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name></person-group><article-title>LLPSDB: a database of proteins undergoing liquid-liquid phase separation in vitro</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D320</fpage>–<lpage>D327</lpage>.<pub-id pub-id-type="pmid">31906602</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meszaros</surname><given-names>B.</given-names></string-name>, <string-name><surname>Erdos</surname><given-names>G.</given-names></string-name>, <string-name><surname>Szabo</surname><given-names>B.</given-names></string-name>, <string-name><surname>Schad</surname><given-names>E.</given-names></string-name>, <string-name><surname>Tantos</surname><given-names>A.</given-names></string-name>, <string-name><surname>Abukhairan</surname><given-names>R.</given-names></string-name>, <string-name><surname>Horvath</surname><given-names>T.</given-names></string-name>, <string-name><surname>Murvai</surname><given-names>N.</given-names></string-name>, <string-name><surname>Kovacs</surname><given-names>O.P.</given-names></string-name>, <string-name><surname>Kovacs</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>PhaSePro: the database of proteins driving liquid-liquid phase separation</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D360</fpage>–<lpage>D367</lpage>.<pub-id pub-id-type="pmid">31612960</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sehnal</surname><given-names>D.</given-names></string-name>, <string-name><surname>Bittrich</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>M.</given-names></string-name>, <string-name><surname>Svobodova</surname><given-names>R.</given-names></string-name>, <string-name><surname>Berka</surname><given-names>K.</given-names></string-name>, <string-name><surname>Bazgier</surname><given-names>V.</given-names></string-name>, <string-name><surname>Velankar</surname><given-names>S.</given-names></string-name>, <string-name><surname>Burley</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Koca</surname><given-names>J.</given-names></string-name>, <string-name><surname>Rose</surname><given-names>A.S.</given-names></string-name></person-group><article-title>Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>W431</fpage>–<lpage>W437</lpage>.<pub-id pub-id-type="pmid">33956157</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jumper</surname><given-names>J.</given-names></string-name>, <string-name><surname>Evans</surname><given-names>R.</given-names></string-name>, <string-name><surname>Pritzel</surname><given-names>A.</given-names></string-name>, <string-name><surname>Green</surname><given-names>T.</given-names></string-name>, <string-name><surname>Figurnov</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ronneberger</surname><given-names>O.</given-names></string-name>, <string-name><surname>Tunyasuvunakool</surname><given-names>K.</given-names></string-name>, <string-name><surname>Bates</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zidek</surname><given-names>A.</given-names></string-name>, <string-name><surname>Potapenko</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title>. <source>Nature</source>. <year>2021</year>; <volume>596</volume>:<fpage>583</fpage>–<lpage>589</lpage>.<pub-id pub-id-type="pmid">34265844</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Varadi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Nair</surname><given-names>S.</given-names></string-name>, <string-name><surname>Sillitoe</surname><given-names>I.</given-names></string-name>, <string-name><surname>Tauriello</surname><given-names>G.</given-names></string-name>, <string-name><surname>Anyango</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bienert</surname><given-names>S.</given-names></string-name>, <string-name><surname>Borges</surname><given-names>C.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>M.</given-names></string-name>, <string-name><surname>Green</surname><given-names>T.</given-names></string-name>, <string-name><surname>Hassabis</surname><given-names>D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>3D-Beacons: decreasing the gap between protein sequences and structures through a federated network of protein structure data resources</article-title>. <source>Gigascience</source>. <year>2022</year>; <volume>11</volume>:<fpage>giac118</fpage>.<pub-id pub-id-type="pmid">36448847</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Varadi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Anyango</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>M.</given-names></string-name>, <string-name><surname>Nair</surname><given-names>S.</given-names></string-name>, <string-name><surname>Natassia</surname><given-names>C.</given-names></string-name>, <string-name><surname>Yordanova</surname><given-names>G.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Stroe</surname><given-names>O.</given-names></string-name>, <string-name><surname>Wood</surname><given-names>G.</given-names></string-name>, <string-name><surname>Laydon</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D439</fpage>–<lpage>D444</lpage>.<pub-id pub-id-type="pmid">34791371</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mirdita</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schutze</surname><given-names>K.</given-names></string-name>, <string-name><surname>Moriwaki</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Heo</surname><given-names>L.</given-names></string-name>, <string-name><surname>Ovchinnikov</surname><given-names>S.</given-names></string-name>, <string-name><surname>Steinegger</surname><given-names>M.</given-names></string-name></person-group><article-title>ColabFold: making protein folding accessible to all</article-title>. <source>Nat. Methods</source>. <year>2022</year>; <volume>19</volume>:<fpage>679</fpage>–<lpage>682</lpage>.<pub-id pub-id-type="pmid">35637307</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Jang</surname><given-names>H.</given-names></string-name></person-group><article-title>AlphaFold, artificial intelligence (AI), and allostery</article-title>. <source>J. Phys. Chem. B</source>. <year>2022</year>; <volume>126</volume>:<fpage>6372</fpage>–<lpage>6383</lpage>.<pub-id pub-id-type="pmid">35976160</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hatos</surname><given-names>A.</given-names></string-name>, <string-name><surname>Tosatto</surname><given-names>S.C.E.</given-names></string-name>, <string-name><surname>Vendruscolo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fuxreiter</surname><given-names>M.</given-names></string-name></person-group><article-title>FuzDrop on AlphaFold: visualizing the sequence-dependent propensity of liquid-liquid phase separation and aggregation of proteins</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>W337</fpage>–<lpage>W344</lpage>.<pub-id pub-id-type="pmid">35610022</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Morales</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>MacRaild</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Seow</surname><given-names>J.</given-names></string-name>, <string-name><surname>Krishnarjuna</surname><given-names>B.</given-names></string-name>, <string-name><surname>Drinkwater</surname><given-names>N.</given-names></string-name>, <string-name><surname>Rouet</surname><given-names>R.</given-names></string-name>, <string-name><surname>Anders</surname><given-names>R.F.</given-names></string-name>, <string-name><surname>Christ</surname><given-names>D.</given-names></string-name>, <string-name><surname>McGowan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Norton</surname><given-names>R.S.</given-names></string-name></person-group><article-title>Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate</article-title>. <source>Sci. Rep.</source><year>2015</year>; <volume>5</volume>:<fpage>10103</fpage>.<pub-id pub-id-type="pmid">25965408</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leach</surname><given-names>B.I.</given-names></string-name>, <string-name><surname>Kuntimaddi</surname><given-names>A.</given-names></string-name>, <string-name><surname>Schmidt</surname><given-names>C.R.</given-names></string-name>, <string-name><surname>Cierpicki</surname><given-names>T.</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Bushweller</surname><given-names>J.H.</given-names></string-name></person-group><article-title>Leukemia fusion target AF9 is an intrinsically disordered transcriptional regulator that recruits multiple partners via coupled folding and binding</article-title>. <source>Structure</source>. <year>2013</year>; <volume>21</volume>:<fpage>176</fpage>–<lpage>183</lpage>.<pub-id pub-id-type="pmid">23260655</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gogl</surname><given-names>G.</given-names></string-name>, <string-name><surname>Alexa</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kiss</surname><given-names>B.</given-names></string-name>, <string-name><surname>Katona</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kovacs</surname><given-names>M.</given-names></string-name>, <string-name><surname>Bodor</surname><given-names>A.</given-names></string-name>, <string-name><surname>Remenyi</surname><given-names>A.</given-names></string-name>, <string-name><surname>Nyitray</surname><given-names>L.</given-names></string-name></person-group><article-title>Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: modulation of the extracellular signal-regulated kinase (ERK) signaling cascade in a calcium-dependent way</article-title>. <source>J. Biol. Chem.</source><year>2016</year>; <volume>291</volume>:<fpage>11</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">26527685</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gross</surname><given-names>J.D.</given-names></string-name>, <string-name><surname>Moerke</surname><given-names>N.J.</given-names></string-name>, <string-name><surname>von der Haar</surname><given-names>T.</given-names></string-name>, <string-name><surname>Lugovskoy</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Sachs</surname><given-names>A.B.</given-names></string-name>, <string-name><surname>McCarthy</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Wagner</surname><given-names>G.</given-names></string-name></person-group><article-title>Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E</article-title>. <source>Cell</source>. <year>2003</year>; <volume>115</volume>:<fpage>739</fpage>–<lpage>750</lpage>.<pub-id pub-id-type="pmid">14675538</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Frederick</surname><given-names>K.K.</given-names></string-name>, <string-name><surname>Debelouchina</surname><given-names>G.T.</given-names></string-name>, <string-name><surname>Kayatekin</surname><given-names>C.</given-names></string-name>, <string-name><surname>Dorminy</surname><given-names>T.</given-names></string-name>, <string-name><surname>Jacavone</surname><given-names>A.C.</given-names></string-name>, <string-name><surname>Griffin</surname><given-names>R.G.</given-names></string-name>, <string-name><surname>Lindquist</surname><given-names>S.</given-names></string-name></person-group><article-title>Distinct prion strains are defined by amyloid core structure and chaperone binding site dynamics</article-title>. <source>Chem. Biol.</source><year>2014</year>; <volume>21</volume>:<fpage>295</fpage>–<lpage>305</lpage>.<pub-id pub-id-type="pmid">24485763</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
